FINWIRES · TerminalLIVE
FINWIRES

BlinkLab Targeting Opportunities Beyond Flagship Autism Program

By

BlinkLab (ASX:BB1) is expanding its study portfolio to evaluate its smartphone-based neurometric platform across additional neurological and psychiatric conditions beyond the company's flagship autism diagnostic program, according to a Tuesday filing with the Australian bourse.

The company said it has 10 ongoing clinical development programs aimed at validating new applications, establishing research collaborations, and identifying new commercial opportunities. These include a program for pediatric attention-deficit/hyperactivity disorder, early dementia detection, and spinocerebellar ataxia.

BlinkLab expects to deliver readouts from five programs this year, followed by five additional readouts in 2027, per the filing.

The company is also targeting a US Food and Drug Administration submission for its BlinkLab Dx1 diagnostic product by the end of the year.

BlinkLab's shares fell past 2% in recent Tuesday trade.

Related Articles

Wire

Rithm Property Trust Launches Public Offering of Common Shares

Rithm Property Trust (RPT) said late Monday it launched a public offering of common shares.The company will grant underwriters a 30-day overallotment option to buy an additional 15% of the shares offered, according to a statement.An affiliate Rithm Capital has shown interest in buying common shares in a concurrent private placement, according to the company.Net proceeds will be used to acquire a portfolio of multifamily residential transition loans from affiliates of Rithm Capital, and for general corporate purposes, the company said.

$RPT
Wire

Penguin Solutions Plans $650 Million Convertible Notes Offering

Penguin Solutions (PENG) intends to offer $650 million in convertible senior notes due 2031 to institutional buyers, with initial purchasers expected to receive an option to buy up to an additional $100 million in notes, the company said Monday in a statement.Penguin expects to use the net proceeds to fund capped call transactions, pay the cash portion of exchanges for its existing 2029 and 2030 convertible notes, repay $100 million outstanding under its credit agreement, and for general corporate purposes.The company's shares fell 4.4% in after-hours trading.

$PENG
Wire

Erasca Plans $500 Million Underwritten Offering of Common Stock

Erasca (ERAS) plans to sell $500 million in common stock in an underwritten public offering.Underwriters are expected to receive a 30-day option to buy up to an additional $75 million in shares, the company said Monday in a statement.Erasca expects to use the net proceeds to finance research and development, and for working capital and general corporate purposes.The company's shares fell 2.2% in after-hours trading.

$ERAS